NMR is being used to non-invasively map the layers of paint in old masterpieces.

A facility dedicated to the production of monoclonal antibodies which can be used for research into cardiovascular disease, neurological disorders, inflammation, brain diseases and cancer has opened in Melbourne. The Monoclonal Antibody Technologies Facility comes from collaboration between the Commonwealth and Victorian governments and Monash University.

A new grants program linking NSW and South Korea in joint technology projects has been announced. Preliminary applications for the grants will close on 30 September and final applications on 15 November.

Collaboration grants open for NSW-Gangwon technology projects [ + ]

Hexima to partner with DuPont for new fungal resistance technology [ + ]

Biotron commences phase Ib/IIa testing of HCV treatment [ + ]

UK researchers find unsual levels of telomerase in cells of endometriosis sufferers [ + ]

Evado clinical trial software taken up by Ventracor [ + ]

Viruses come alive as French scientists discover new family of viruses that infects others [ + ]

Australian medical device company Ventracor is so pleased with its clinical trial design, it's decided to apply for a patent for it. [ + ]

Fresh from his role as one of the head spruikers of Queensland biotech at BIO in San Diego and DIA in Boston, the CEO of the Queensland Clinical Trials Network, Mario Pennisi, is looking forward to hosting CRX08. [ + ]

Patients achieve bone union in long-time non-healing bones after implantation of Mesoblast's adult stem cells [ + ]

Bad news for Biosignal on Ciba evaluation agreement [ + ]

ResMed's share price soars following impressive fourth-quarter and financial year earnings figures. [ + ]

HeartWare to transfer corporate responsibility to US [ + ]